← Every applicant
Zhejiang Poly Pharm FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BRIVARACETAMNew drugFeb 23, 2026SOLUTION, ORAL |
| AMIODARONE HYDROCHLORIDENew drugSep 11, 2024INJECTABLE, INJECTION |
| VORICONAZOLENew drugJan 2, 2024FOR SUSPENSION, ORAL |
| OSELTAMIVIR PHOSPHATENew drugNov 24, 2023CAPSULE, ORAL |
| FLUCONAZOLENew drugSep 21, 2023FOR SUSPENSION, ORAL |
| AZITHROMYCINNew drugJul 27, 2023FOR SUSPENSION, ORAL |